BioLineRx Ltd. (TLV: BLRX)
Israel
· Delayed Price · Currency is ILS · Price in ILA
3.500
-0.200 (-5.41%)
Jan 19, 2025, 3:49 PM IDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of 79.00 million as of January 22, 2025. Its market cap has decreased by -80.91% in one year.
Market Cap
79.00M
Enterprise Value
80.64M
Revenue
81.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.50
Market Cap Chart
Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 79.00M, an increase of 48,358.07%. That is a compound annual growth rate of 41.12%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 88.56B |
Danel (Adir Yeoshua) | 2.53B |
Kamada | 1.45B |
Bait Bakfar | 1.05B |
Novolog (Pharm-Up 1966) | 973.94M |
Ilex Medical | 834.54M |
BrainsWay | 710.39M |
SofWave Medical | 603.50M |